Skip to main content
Erschienen in: World Journal of Surgery 8/2015

01.08.2015 | Original Scientific Report

Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma

verfasst von: Hwan Seo Lee, Jong-Lyel Roh, Gyungyup Gong, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim

Erschienen in: World Journal of Surgery | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Papillary thyroid carcinoma (PTC) is generally an indolent tumor indicative of favorable prognosis. However, post-treatment recurrences may be problematic, and management strategies for recurrent disease have not been established. This study investigated risk factors associated with re-recurrence of PTC after reoperative surgery.

Materials and methods

This study included 151 patients with pathologically confirmed recurrent/persistent PTC who underwent reoperation. Clinical factors, operative and pathologic findings, serum thyroglobulin levels, postoperative complications, and recurrences were examined. Univariate and multivariate analyses were performed to identify factors associated with re-recurrence-free survival (RFS) after reoperative surgery.

Results

Recurrent tumors were found in thyroid remnants or previous resection bed (n = 28), central nodes (n = 48), and lateral neck nodes (n = 102). Biochemical complete remission (stimulated thyroglobulin <1 ng/mL) was achieved in 69 (51.5 %) patients after reoperative surgery. Permanent vocal fold paralysis and hypoparathyroidism developed in 6 (4.1 %) and 4 (2.8 %) patients, respectively. Vocal fold paralysis occurred primarily due to intentional nerve resection following tumor invasion. During a median follow-up of 57.5 months, 41 (27.2 %) patients had re-recurrences. Univariate analyses showed that extranodal extension (p = 0.028), recurrent laryngeal nerve invasion (p = 0.037), as well as stimulated (p = 0.001) and unstimulated (p = 0.015) serum thyroglobulin were significant predictors of RFS. Multivariate analyses showed that postoperative biochemical remission independently predicted RFS (p = 0.014).

Conclusions

Postoperative thyroglobulin after reoperative surgery predicted re-recurrence. Careful follow-up of these patients after reoperation is recommended.
Literatur
1.
Zurück zum Zitat Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172(6):692–694PubMedCrossRef Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172(6):692–694PubMedCrossRef
2.
Zurück zum Zitat Lee CW, Roh JL, Gong G et al (2014) Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol. 22(1):117–124PubMedCrossRef Lee CW, Roh JL, Gong G et al (2014) Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol. 22(1):117–124PubMedCrossRef
3.
Zurück zum Zitat Randolph GW, Duh QY, Heller KS, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11):1144–1152PubMedCrossRef Randolph GW, Duh QY, Heller KS, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11):1144–1152PubMedCrossRef
4.
Zurück zum Zitat Kim SJ, Park SY, Lee YJ et al (2014) Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. Ann Surg Oncol 21(6):1884–1890PubMedCrossRef Kim SJ, Park SY, Lee YJ et al (2014) Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. Ann Surg Oncol 21(6):1884–1890PubMedCrossRef
5.
Zurück zum Zitat Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36(6):1274–1278. doi:10.1007/s00268-012-1423-5 PubMedCrossRef Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36(6):1274–1278. doi:10.​1007/​s00268-012-1423-5 PubMedCrossRef
6.
Zurück zum Zitat Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106(3):524–531PubMedCrossRef Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106(3):524–531PubMedCrossRef
8.
Zurück zum Zitat Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428PubMedCrossRef Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428PubMedCrossRef
9.
Zurück zum Zitat Kim MK, Mandel SH, Baloch Z et al (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130(10):1214–1216PubMedCrossRef Kim MK, Mandel SH, Baloch Z et al (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130(10):1214–1216PubMedCrossRef
10.
Zurück zum Zitat Roh JL, Kim JM, Park CI (2011) Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 18(8):2245–2250PubMedCrossRef Roh JL, Kim JM, Park CI (2011) Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 18(8):2245–2250PubMedCrossRef
11.
Zurück zum Zitat Al-Saif O, Farrar WB, Bloomston M et al (2010) Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95(5):2187–2194PubMedCrossRef Al-Saif O, Farrar WB, Bloomston M et al (2010) Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95(5):2187–2194PubMedCrossRef
12.
Zurück zum Zitat Yim JH, Kim WB, Kim EY et al (2011) The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96(7):2049–2056PubMedCrossRef Yim JH, Kim WB, Kim EY et al (2011) The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96(7):2049–2056PubMedCrossRef
13.
Zurück zum Zitat Hughes DT, Laird AM, Miller BS et al (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957PubMedCrossRef Hughes DT, Laird AM, Miller BS et al (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957PubMedCrossRef
14.
Zurück zum Zitat Schuff KG, Weber SM, Givi B et al (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118(5):768–775PubMedCrossRef Schuff KG, Weber SM, Givi B et al (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118(5):768–775PubMedCrossRef
15.
Zurück zum Zitat Lang BH, Wong KP, Wan KY (2013) Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma. Ann Surg Oncol 20(2):653–659PubMedCrossRefPubMedCentral Lang BH, Wong KP, Wan KY (2013) Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma. Ann Surg Oncol 20(2):653–659PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat McCaffrey TV, Lipton RJ (1990) Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope 100(8):824–830PubMedCrossRef McCaffrey TV, Lipton RJ (1990) Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope 100(8):824–830PubMedCrossRef
17.
Zurück zum Zitat Johnson S, Goldenberg D (2008) Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery. Otolaryngol Clin North Am 41(6):1147–1154PubMedCrossRef Johnson S, Goldenberg D (2008) Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery. Otolaryngol Clin North Am 41(6):1147–1154PubMedCrossRef
19.
Zurück zum Zitat Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237(3):399–407PubMedPubMedCentral Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237(3):399–407PubMedPubMedCentral
20.
Zurück zum Zitat Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245(4):604–610PubMedCrossRefPubMedCentral Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245(4):604–610PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134(5):536–538PubMedCrossRef Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134(5):536–538PubMedCrossRef
22.
Zurück zum Zitat Olson JA Jr, DeBenedetti MK, Baumann DS et al (1996) Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 223(5):472–478PubMedCrossRefPubMedCentral Olson JA Jr, DeBenedetti MK, Baumann DS et al (1996) Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 223(5):472–478PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214PubMedCrossRef
24.
Zurück zum Zitat Kim TY, Kim WB, Kim ES et al (2005) Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90(3):1440–1445PubMedCrossRef Kim TY, Kim WB, Kim ES et al (2005) Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90(3):1440–1445PubMedCrossRef
26.
Zurück zum Zitat Pitoia F, Bueno F, Urciuoli C et al (2013) Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems. Thyroid 23(11):1401–1407PubMedCrossRef Pitoia F, Bueno F, Urciuoli C et al (2013) Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems. Thyroid 23(11):1401–1407PubMedCrossRef
27.
Zurück zum Zitat Shim MJ, Roh JL, Gong G et al (2013) Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br J Surg 100(4):497–503PubMedCrossRef Shim MJ, Roh JL, Gong G et al (2013) Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br J Surg 100(4):497–503PubMedCrossRef
28.
Zurück zum Zitat Lango M, Flieder D, Arrangoiz R et al (2013) Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid 23(9):1099–1105PubMedCrossRefPubMedCentral Lango M, Flieder D, Arrangoiz R et al (2013) Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid 23(9):1099–1105PubMedCrossRefPubMedCentral
Metadaten
Titel
Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma
verfasst von
Hwan Seo Lee
Jong-Lyel Roh
Gyungyup Gong
Kyung-Ja Cho
Seung-Ho Choi
Soon Yuhl Nam
Sang Yoon Kim
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2015
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3052-2

Weitere Artikel der Ausgabe 8/2015

World Journal of Surgery 8/2015 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.